Peptides in California: what’s legal, and what to avoid
Search “peptides” in California and you’ll find two completely different worlds wearing the same name. One is regulated medicine: FDA-approved peptide drugs and a small number of lawfully compounded preparations, prescribed by a licensed clinician and dispensed by a licensed pharmacy. The other is a sprawl of online vendors selling vials labeled research use only — a label that shifts legal risk to you rather than making the product legitimate. This page separates the two, honestly: what’s actually legal in California, how a legitimate prescription works here, and the red flags that tell you a seller has left medicine entirely.
What’s actually legal in California
A peptide is just a short chain of amino acids — insulin is a peptide, and so are the GLP-1 medications (GLP-1 stands for glucagon-like peptide-1). Being “a peptide” says nothing about whether a product is approved, effective, or legal. In California, as everywhere in the US, the legitimate options fall into two lanes:
FDA-approved peptide drugs
These went through the full approval process — large trials, defined manufacturing, labeled dosing, post-market safety monitoring. The list is longer than most people expect: insulin; semaglutide (Wegovy®, Ozempic®), tirzepatide (Zepbound®, Mounjaro®), and liraglutide (Saxenda®); teriparatide (Forteo®) for osteoporosis; tesamorelin (Egrifta®) for HIV-associated lipodystrophy; bremelanotide (Vyleesi®) for hypoactive sexual desire disorder. Each is approved for a specific use, in a specific product, and is prescription-only — a licensed clinician decides whether it’s appropriate for you.
Lawfully compounded preparations
A second, narrower lane: preparations a state-licensed compounding pharmacy may prepare for a specific patient against a valid prescription, under §503A of federal law. Very few peptides qualify — the ingredient must have a lawful compounding pathway, which the headline “research peptides” do not. Sermorelin, a synthetic analog of growth hormone-releasing hormone (GHRH), is one that does. Our plain-English guide to the FDA’s compounding rules covers exactly which line separates the two — it’s the most misrepresented fact in this market.
The “research use only” market
The peptides most heavily marketed online — BPC-157, TB-500, ipamorelin, CJC-1295, and similar — are not FDA-approved for any use and are not on the FDA’s list of substances allowed in pharmacy compounding. No licensed pharmacy in California or any other state may legally prepare them. That’s why they’re sold with “research use only” labels: the sticker exists to shift legal risk to the buyer, not to make the product legitimate. It also means there is no verified chain of custody for identity, purity, or sterility — a vial might contain what the label says, in the dose the label says, prepared sterilely. Or it might not, and there’s no way for the buyer to know.
Red flags, in order of importance: no prescription required; “research use only” or “not for human consumption” labels; no named, licensed pharmacy; no licensed clinician anywhere in the process; payment by wire, crypto, or app only. Any one of these is disqualifying — regardless of price, reviews, or how scientific the website looks.
A California prescription and a research-vial checkout, step by step. The chain is what makes a medicine a medicine.
A California prescription
- Online intakeYour health history and goals — about five minutes.
- Licensed clinician reviewsA clinician licensed by the Medical Board of California prescribes only when clinically appropriate.
- Licensed US pharmacy prepares itPrepared per-patient; out-of-state pharmacies hold a non-resident California license.
- Ships to your door2–3 business days, tracked — with ongoing care by secure message.
A research-vial checkout
- Add to cartNo health questions asked, no eligibility review.
- No clinician anywhereNobody licensed ever decides whether this is appropriate for you.
- No pharmacy — a label instead“Research use only” shifts the legal risk to the buyer.
- An unverified vialIdentity, purity, and sterility unknown; no one is accountable.
How a legitimate prescription works in California
Every legitimate pathway in California runs through the same chain, and every illegitimate one skips it. A clinician licensed by the Medical Board of California reviews your health history and decides whether a treatment is clinically appropriate — for you, specifically. California allows asynchronous telehealth, so most care happens by secure message — no video call required. When something is prescribed, a licensed US pharmacy prepares and ships it; out-of-state pharmacies shipping into California must hold a non-resident pharmacy license here. Shipping to Los Angeles, San Diego, San Jose, and everywhere else in California, typically takes 2–3 business days. If a seller can’t name the clinician who reviewed you or the pharmacy that prepared your medication, you’re not looking at telehealth — you’re looking at a storefront.
43 of 50 states are fully async; 7 states plus Washington, D.C. require one video visit. California: fully async — no video visit.
43 of 50 states allow fully asynchronous telehealth prescribing. Arkansas, Mississippi, New Mexico, North Dakota, Rhode Island, South Dakota, and West Virginia, plus Washington, D.C., require one live video visit to establish care. California allows fully asynchronous care.
Physicians prescribe in every state. Nurse practitioner authority is the axis that differs — in California, nurse practitioners prescribe under physician delegation or supervision: Standardized procedures (furnishing); independent practice available via AB 890 certification.
Cal. Bus. & Prof. Code §2836.1; §2837.103–.104 · verified 2026-07-27
In California, nurse practitioner prescriptive authority is classified as restricted practice: Standardized procedures (furnishing); independent practice available via AB 890 certification. Source: Cal. Bus. & Prof. Code §2836.1; §2837.103–.104, verified 2026-07-27.
What Pallas offers in California
Pallas evaluates compounds one at a time, and the bar is the law — not the demand. Two clinician-prescribed programs are available to California adults today, each on its own page, each prescribed only when a US-licensed clinician decides it’s clinically appropriate:
- Compounded sermorelinA synthetic analog of growth hormone-releasing hormone (GHRH) — the signal the body uses to prompt the pituitary gland's own growth hormone release. $89 for your first month, then $597 every 12 weeks ($199/mo average). Cancel anytime.
- NAD+ — often searched as a peptide; it isn’t oneNAD+ is a coenzyme your cells use in energy metabolism — chemically a different category, though it travels in the same conversations. Available as a clinician-prescribed injection or nasal spray, from $79 for your first month.
And if weight loss is what brought you here: the peptide-class medications with FDA approval for chronic weight management are the GLP-1s — semaglutide and tirzepatide — not anything sold in a research vial. That path has its own page: GLP-1 weight loss in California.
Frequently asked questions
It depends entirely on which peptide, obtained how. FDA-approved peptide drugs — insulin, the GLP-1 medications, and others — are legal in California with a valid prescription, like any prescription medicine. A small number of other compounds, such as sermorelin, have a lawful compounding pathway: a licensed clinician prescribes them for a specific patient and a state-licensed compounding pharmacy prepares them. The "research use only" peptides sold online — BPC-157, TB-500, ipamorelin, and similar — are not approved for human use anywhere in the US, including California; the label doesn't create an exception, it signals that no one is accountable for what's in the vial.
More than most people expect — but not the ones the vendor sites sell. Approved peptide drugs include insulin; the GLP-1 medications semaglutide (Wegovy®, Ozempic®), tirzepatide (Zepbound®, Mounjaro®), and liraglutide (Saxenda®, Victoza®); teriparatide (Forteo®) for osteoporosis; tesamorelin (Egrifta®) for HIV-associated lipodystrophy; and bremelanotide (Vyleesi®) for hypoactive sexual desire disorder in premenopausal women. One important nuance: approval belongs to a specific product for a specific use — the same molecule's name on a "research grade" vial does not inherit that approval.
For specific compounds with a lawful pathway, yes. Telehealth prescribing is legal in California: a clinician licensed by the Medical Board of California reviews your health history and, when clinically appropriate, can prescribe an FDA-approved peptide drug or a lawfully compoundable preparation such as sermorelin, dispensed by a licensed pharmacy. What no legitimate telehealth service can do is prescribe the research compounds — no licensed pharmacy may prepare them, in California or any other state. A site offering them without a prescription isn't practicing telehealth; it's retailing unapproved drugs.
No — and it's one of the most common mix-ups in this space. NAD+ (nicotinamide adenine dinucleotide) is a coenzyme, a molecule your cells use in energy metabolism; peptides are chains of amino acids. NAD+ gets grouped with peptides because the same clinics and wellness programs tend to offer both, but chemically they're different categories. The practical questions are the same, though: is a licensed clinician reviewing your health history, and is a licensed pharmacy preparing what you receive?
It means the product is not a medicine and no one in the chain is accountable for it being one. "Research use only" and "not for human consumption" labels exist to shift legal risk to the buyer — they do not make an unapproved compound legitimate. Per the FDA, a peptide intended for human use is regulated as a drug, and selling it for human use without approval or a valid prescription is unlawful regardless of the label. Practically, it also means no verified identity, purity, or sterility: there's no licensed pharmacy or FDA-registered manufacturer standing behind the vial.
No. California allows asynchronous telehealth care, so a clinician can review your intake and prescribe, when appropriate, without a video call — most patients complete everything by secure message. A clinician may still request a call if they need more information.
No. Compounded preparations — including the sermorelin and NAD+ programs Pallas offers — are prepared per-patient by state-licensed US compounding pharmacies and are not FDA-approved. That is exactly why the process starts with a US-licensed clinician who reviews your health history and prescribes only when clinically appropriate — and why the sourcing runs through FDA-registered ingredient suppliers rather than a gray-market channel.
The honest answer: "peptide" is a chemistry term, not a safety rating, so the question only makes sense one compound and one source at a time. FDA-approved peptide drugs have defined dosing, published safety data, and post-market monitoring — and still require a clinician's judgment about whether they're appropriate for you. A research-vial peptide has none of that: no verified contents, no sterility assurance, no accountable manufacturer, and in most cases little or no human safety data. Whatever the compound, the pathway is the safety question.
Clinician-prescribed care, available in California
The online intake takes about five minutes. A US-licensed clinician reviews your health history and prescribes only when clinically appropriate — and tells you honestly if it’s not a fit.